Uninterrupted Dabigatran Etexilate in Comparison to Uninterrupted Warfarin in Pulmonary Vein Ablation (RE-CIRCUIT)

NCT02348723 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

678

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: Warfarin
DRUG: Dabigatran Etexilate 150mg

Sponsor

Boehringer Ingelheim